Revere Asset Management Inc Acquires Shares of 3,542 Astera Labs, Inc. $ALAB

Revere Asset Management Inc acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 3,542 shares of the company’s stock, valued at approximately $589,000. Astera Labs comprises about 0.2% of Revere Asset Management Inc’s portfolio, making the stock its 21st biggest position.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Nordea Investment Management AB bought a new position in Astera Labs in the fourth quarter valued at approximately $2,028,000. Geneva Partners LLC bought a new position in Astera Labs in the third quarter valued at approximately $1,876,000. Numerai GP LLC raised its holdings in Astera Labs by 153.1% in the third quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock worth $2,587,000 after purchasing an additional 7,992 shares during the period. Handelsbanken Fonder AB raised its holdings in Astera Labs by 289.5% in the third quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock worth $24,710,000 after purchasing an additional 93,800 shares during the period. Finally, Paragon Advisors LLC acquired a new stake in Astera Labs in the third quarter worth $1,829,000. 60.47% of the stock is owned by institutional investors.

Insider Activity at Astera Labs

In related news, CEO Jitendra Mohan sold 28,737 shares of the firm’s stock in a transaction on Tuesday, May 19th. The shares were sold at an average price of $249.62, for a total transaction of $7,173,329.94. Following the sale, the chief executive officer directly owned 3,789,232 shares in the company, valued at $945,868,091.84. This trade represents a 0.75% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the firm’s stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $200.03, for a total transaction of $701,105.15. Following the sale, the director owned 63,639 shares in the company, valued at approximately $12,729,709.17. The trade was a 5.22% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 1,915,461 shares of company stock valued at $358,508,976. Insiders own 12.50% of the company’s stock.

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $306.88 on Tuesday. Astera Labs, Inc. has a 12 month low of $84.78 and a 12 month high of $315.81. The company’s fifty day simple moving average is $174.13 and its 200 day simple moving average is $160.46. The firm has a market cap of $52.60 billion, a price-to-earnings ratio of 207.35, a PEG ratio of 4.06 and a beta of 3.35.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same period last year, the business posted $0.33 earnings per share. The firm’s quarterly revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Research analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms have weighed in on ALAB. Needham & Company LLC increased their target price on shares of Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Roth Mkm reiterated a “buy” rating and issued a $275.00 target price on shares of Astera Labs in a report on Wednesday, May 6th. Loop Capital began coverage on shares of Astera Labs in a report on Thursday, March 5th. They issued a “buy” rating and a $250.00 target price on the stock. Weiss Ratings upgraded shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday. Finally, Morgan Stanley increased their target price on shares of Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $233.75.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.